Rigel Pharmaceuticals, Inc. (RIGL)

36.96 -0.97 (-2.56%) USD  |  NASDAQ  |  Jan 23, 16:00
37.21 +0.25 (+0.68%) After-Hours: 20:00
More

Rigel Pharmaceuticals Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Nektar Therapeutics Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade